| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.7B | $5.3B | $5.5B | $6.6B | $5.6B | $4.6B | $1.2B | $1.3B |
| Cost of Revenue | — | — | — | — | — | — | $2.0B | $2.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.2B | $0.2B | $0.3B | $0.6B | $0.5B | $0.3B | $0.1B | $0.1B |
| Net Income | $0.1B | $0.1B | $0.2B | $0.5B | $0.4B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $0.59 | $0.67 | $1.35 | $2.57 | $2.28 | $1.19 | $0.32 | $0.48 |
| EPS (Diluted) | $0.59 | $0.66 | $1.34 | $2.56 | $2.28 | $1.19 | $0.32 | $0.48 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.8B | $4.9B | $4.6B | $4.3B | $3.9B | $3.5B | $3.7B | $3.6B |
| Current Assets | $1.2B | $1.1B | $1.1B | $1.4B | $1.2B | $1.2B | $1.4B | $1.3B |
| Cash & Equivalents | — | — | — | $0.4B | $0.2B | $0.4B | $0.6B | $0.4B |
| Total Liabilities | $1.8B | $1.9B | $1.6B | $1.5B | $1.5B | $1.5B | $1.4B | — |
| Current Liabilities | $0.6B | $0.7B | $0.6B | $0.6B | $0.7B | $0.5B | $0.5B | $0.5B |
| Stockholders' Equity | $3.0B | $3.0B | $3.0B | $2.8B | $2.4B | $2.1B | $2.2B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.7B | $0.7B | $0.9B | $0.6B | $0.6B | $0.6B | $0.6B |
| Investing Cash Flow | $-0.3B | $-0.8B | $-0.9B | $-0.6B | $-0.6B | $-0.3B | $-0.4B | $-0.3B |
| Capital Expenditures | $0.4B | $0.4B | $0.7B | $0.5B | $0.4B | $0.3B | $0.3B | $0.4B |
| Financing Cash Flow | $-0.2B | $0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.5B | $-0.1B | $-0.1B |